Contravisory Investment Management, Inc. Amneal Pharmaceuticals, Inc. Transaction History
Contravisory Investment Management, Inc.
- $450 Million
- Q1 2025
A detailed history of Contravisory Investment Management, Inc. transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Contravisory Investment Management, Inc. holds 31,454 shares of AMRX stock, worth $226,783. This represents 0.06% of its overall portfolio holdings.
Number of Shares
31,454Holding current value
$226,783% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding AMRX
# of Institutions
207Shares Held
124MCall Options Held
362KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA14.8MShares$107 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$88.9 Million2.69% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$81.3 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$77.3 Million1.4% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il8.98MShares$64.8 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.09B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...